JAVMA news
Members appointed to compounding task force, other entities
In early June, the AVMA appointed eight veterinarians to the Task Force on Veterinary Compounding Legislation
JAVMA news
FDA to revise Compliance Policy Guide on veterinary compounding
The current CPG, published in July 2003, describes the FDA's position on what types of veterinary compounding might be subject to enforcement action.
blog
USP agrees to consider need for veterinary-specific compounding rules
The United States Pharmacopeia (USP), which sets pharmaceutical standards that apply to both human and veterinary medicine, will consider the AVMA’s…
blog
AVMA prepares response to FDA draft compounding guidance
Based on feedback from member veterinarians and other stakeholders, the AVMA has compiled a list of key points to share with the FDA in our formal…
JAVMA news
Battles over compounding from bulk drugs move forward
Animal drug compounding from bulk drug substances has become a heated issue since the Food and Drug Administration
JAVMA news
FDA describes legal limits of drug compounding
Agency says few uses allowed for raw active ingredients
JAVMA news
Company halts animal-use drug compounding during talks with government
A Florida laboratory has stopped compounding drugs for animal use and will allow federal inspectors to visit the business
blog
FDA extends comment deadline on compounding guidance
The action follows AVMA's request for more review time.
JAVMA news
Compounding case against BET Pharm settled
On Sept. 25, U.S. District Judge Karl Forester filed a consent decree in a civil case between the United States and the
blog
Compounding: New webinar outlines FDA final guidance #256
Gain a solid overview of the FDA's guidance on compounding animal drugs from bulk drug substances, and learn how it impacts veterinarians and our…
JAVMA news
FDA files appeal in drug compounding case
The Food and Drug Administration filed an appeal Dec. 1 in the case Medical Center Pharmacy, et al. v. Gonzalez, et al. in the U.S. District Court for…
blog
AVMA weighs in on compounding guidance, provides new FAQ resource
AVMA has submitted comments to the FDA on the agency’s proposed guidance on compounding from bulk substances (GFI #256). A new resource answers…
blog
FDA releases final guidance on compounding from bulk substances
The U.S. Food and Drug Administration has published final guidance describing the conditions under which it does not intend to take enforcement action…
JAVMA news
Bayer receives injunction against drug compounder
Bayer HealthCare LLC's Animal Health Division on May 5 received a favorable court order in its lawsuit against Tabor Home Medical
JAVMA news
Practice inefficiencies compound veterinary stress
A high number of veterinarians say they are considering leaving their dream job for reasons unrelated to retirement. The surprising trend was one of…
blog
New webinar explains proposed rules on bulk compounding
The information is important to help veterinarians provide informed feedback to the FDA during the public comment period for its draft guidance.
blog
AVMA asks FDA to extend comment period on animal drug compounding
We asked the agency to clarify its latest proposal to regulate animal drug compounding from bulk substances, and allow at least a 120-day extension…
JAVMA news
Internet pharmacies and compounding are high-priority areas, FDA says
Posted on March 1, 2002 Since prior coverage on the issue of Internet pharmacies (see JAVMA, June 1, 2001, and Aug. 15, 2001), the AVMA continues…
AVMA news
FDA extends educational period for new policy on compounding animal drugs from bulk drug substances
The Food and Drug Administration has delayed enforcement of its finalized guidance regarding compounding animal drugs from bulk drug substances.
JAVMA news
Compound could treat foal pneumonia without promoting drug resistance
Gallium maltolate could be a viable alternative for treating foal pneumonia without promoting drug resistance.
blog
FDA grants AVMA request to extend comments on compounding from bulk drugs
The extension means AVMA members have until April 20 to provide feedback to inform the AVMA's formal comments on the proposal.
recall
Alert: US Compounding recalls all sterile compounded products nationwide
Concern about lack of sterility assurance
recall
Alert: Reliable Drug Pharmacy, all compounded products
lack of quality assurance and potential mislabeling